One of the limitations of this study is that our AAT deficiency model is a knockout mouse, different from AAT deficiency in humans caused by mutations in the SERPINA1 gene and intrahepatic accumulation of misfolded AAT. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.